Home Biosimilar Antibodies Metabolism PCSK9 antibody Bococizumab (Anti-PCSK9) For research use only.
Not for use in humans.

Bococizumab (Anti-PCSK9)

Synonyms: PF-04950615; RN316

Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.

Bococizumab (Anti-PCSK9)

Purity & Quality Control

Batch: A278801 Purity: 99% Protein concentration: 6.18mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective PCSK9 Inhibitors

Name Citation PCSK9
PF-06446846 0
PF-06446846 hydrochloride
SBC-110736
R-IMPP
SBC-115076
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.

Product Details

CAS No. 1407495-02-6
Molecular Weight 145.06
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Bococizumab (Anti-PCSK9) | Bococizumab (Anti-PCSK9) supplier | purchase Bococizumab (Anti-PCSK9) | Bococizumab (Anti-PCSK9) cost | Bococizumab (Anti-PCSK9) manufacturer | order Bococizumab (Anti-PCSK9) | Bococizumab (Anti-PCSK9) distributor